Related Experiment Videos

[A study of intercellular adhesion molecule-1 (ICAM-1) in cervical cancer]

Y Okamoto1, T Tsurunaga, M Ueda

  • 1Department of Obstetrics and Gynecology, Osaka Medical College.

Insights

Intercellular adhesion molecule-1 (ICAM-1) is expressed in cervical cancer and correlates with immune cell infiltration. Cytokines like interferon-gamma and tumor necrosis factor-alpha can increase ICAM-1, suggesting potential for cytokine-based immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Context:

  • Intercellular adhesion molecule-1 (ICAM-1) is crucial for immune cell interactions in target-cell lysis.
  • Cervical cancer involves complex immune responses and cellular interactions.
  • Understanding ICAM-1's role in cervical cancer can inform therapeutic strategies.

Purpose:

  • To investigate the expression of ICAM-1 in cervical cancer tissues and cell lines.
  • To determine the correlation between ICAM-1 expression and immune cell infiltration (CD3+ cells) in cervical cancer.
  • To assess the effect of cytokines, specifically interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), on ICAM-1 expression in cervical cancer cell lines.

Summary:

  • Immunohistochemistry analysis of 15 cervical cancer cases revealed ICAM-1 expression in 4 instances.
  • ICAM-1 expression in cervical cancer tissues positively correlated with the degree of CD3+ mononuclear cell infiltration.
  • In vitro studies showed that IFN-γ and TNF-α significantly augmented ICAM-1 expression on cervical cancer cell lines.

Impact:

  • The findings suggest that ICAM-1 expression in cervical cancer is influenced by cytokines.
  • Increased ICAM-1 expression may enhance the host immune response against cervical cancer.
  • Cytokine-mediated modulation of ICAM-1 presents a potential therapeutic avenue for cervical cancer immunotherapy.

Related Concept Videos